Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt 19.11
PDEX's Cash to Debt is ranked higher than
66% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.81 vs. PDEX: 19.11 )
Ranked among companies with meaningful Cash to Debt only.
PDEX' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.62 Max: No Debt
Current: 19.11
Equity to Asset 0.79
PDEX's Equity to Asset is ranked higher than
77% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.62 vs. PDEX: 0.79 )
Ranked among companies with meaningful Equity to Asset only.
PDEX' s Equity to Asset Range Over the Past 10 Years
Min: 0.24  Med: 0.68 Max: 0.9
Current: 0.79
0.24
0.9
Interest Coverage 10.47
PDEX's Interest Coverage is ranked lower than
62% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.81 vs. PDEX: 10.47 )
Ranked among companies with meaningful Interest Coverage only.
PDEX' s Interest Coverage Range Over the Past 10 Years
Min: 2.52  Med: 12.28 Max: 45.84
Current: 10.47
2.52
45.84
F-Score: 5
Z-Score: 5.79
M-Score: -1.57
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) 2.10
PDEX's Operating margin (%) is ranked lower than
56% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.98 vs. PDEX: 2.10 )
Ranked among companies with meaningful Operating margin (%) only.
PDEX' s Operating margin (%) Range Over the Past 10 Years
Min: -15.47  Med: -6.90 Max: 11.97
Current: 2.1
-15.47
11.97
Net-margin (%) 3.73
PDEX's Net-margin (%) is ranked higher than
52% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.15 vs. PDEX: 3.73 )
Ranked among companies with meaningful Net-margin (%) only.
PDEX' s Net-margin (%) Range Over the Past 10 Years
Min: -14.56  Med: -3.62 Max: 9.74
Current: 3.73
-14.56
9.74
ROE (%) 8.19
PDEX's ROE (%) is ranked higher than
58% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.01 vs. PDEX: 8.19 )
Ranked among companies with meaningful ROE (%) only.
PDEX' s ROE (%) Range Over the Past 10 Years
Min: -32.8  Med: -4.91 Max: 29.43
Current: 8.19
-32.8
29.43
ROA (%) 5.79
PDEX's ROA (%) is ranked higher than
67% of the 203 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. PDEX: 5.79 )
Ranked among companies with meaningful ROA (%) only.
PDEX' s ROA (%) Range Over the Past 10 Years
Min: -19.31  Med: -3.70 Max: 17.69
Current: 5.79
-19.31
17.69
ROC (Joel Greenblatt) (%) 12.08
PDEX's ROC (Joel Greenblatt) (%) is ranked higher than
52% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.53 vs. PDEX: 12.08 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
PDEX' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -37.59  Med: -10.60 Max: 45.53
Current: 12.08
-37.59
45.53
Revenue Growth (3Y)(%) -15.30
PDEX's Revenue Growth (3Y)(%) is ranked lower than
85% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. PDEX: -15.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
PDEX' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -27.9  Med: -3.40 Max: 20.9
Current: -15.3
-27.9
20.9
EPS Growth (3Y)(%) -29.90
PDEX's EPS Growth (3Y)(%) is ranked lower than
84% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.90 vs. PDEX: -29.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
PDEX' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -61.3  Med: -29.90 Max: 103
Current: -29.9
-61.3
103
» PDEX's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-09-17)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with PDEX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:NAS:BLFS, NAS:ATEC, ROCO:6493, XSAT:HEART, TSXV:ERG » details
Traded in other countries:PDXN.Germany,
Pro-Dex Inc with operations in designs and produces powered surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries.

Pro-Dex Inc was incorporated in the State of Colorado. The Company with operations in Irvine, California and Beaverton, Oregon, designs and produces powered surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Companys products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high-tech manufacturing operations internationally. The names Micro Motors, Oregon Micro Systems, and Astromec are used for marketing purposes as brand names. The Companys medical device products utilize under development and supply agreements and are manufactured in Irvine, California facility, as are its dental products. Its medical device products are sold mainly to original equipment manufacturers and its dental products are sold mainly to dental product distributors. In its Beaverton, Oregon facility, it designs and manufactures embedded multi-axis motion controllers which are sold to distributors or original equipment manufacturers in the automation and research industries. The Company competes in all of its markets with other medical device and motion control related companies. As a provider of outsourced services, it also competes with its customers own internal development and manufacturing groups. The manufacture and distribution of medical and dental devices are subject to state and federal requirements set forth by various agencies including state dental boards and the U.S. Food and Drug Administration.

Ratios

vs
industry
vs
history
P/E(ttm) 24.00
PDEX's P/E(ttm) is ranked higher than
55% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.90 vs. PDEX: 24.00 )
Ranked among companies with meaningful P/E(ttm) only.
PDEX' s P/E(ttm) Range Over the Past 10 Years
Min: 2.07  Med: 17.59 Max: 52.41
Current: 24
2.07
52.41
PE(NRI) 24.00
PDEX's PE(NRI) is ranked higher than
56% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.90 vs. PDEX: 24.00 )
Ranked among companies with meaningful PE(NRI) only.
PDEX' s PE(NRI) Range Over the Past 10 Years
Min: 2.19  Med: 17.75 Max: 50.67
Current: 24
2.19
50.67
P/B 1.85
PDEX's P/B is ranked higher than
67% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.69 vs. PDEX: 1.85 )
Ranked among companies with meaningful P/B only.
PDEX' s P/B Range Over the Past 10 Years
Min: 0.27  Med: 0.94 Max: 3.03
Current: 1.85
0.27
3.03
P/S 0.90
PDEX's P/S is ranked higher than
79% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.59 vs. PDEX: 0.90 )
Ranked among companies with meaningful P/S only.
PDEX' s P/S Range Over the Past 10 Years
Min: 0.15  Med: 0.58 Max: 2.47
Current: 0.9
0.15
2.47
EV-to-EBIT 20.54
PDEX's EV-to-EBIT is ranked higher than
51% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.76 vs. PDEX: 20.54 )
Ranked among companies with meaningful EV-to-EBIT only.
PDEX' s EV-to-EBIT Range Over the Past 10 Years
Min: -73.1  Med: -1.80 Max: 37.1
Current: 20.54
-73.1
37.1
EV-to-EBITDA 10.96
PDEX's EV-to-EBITDA is ranked higher than
70% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.58 vs. PDEX: 10.96 )
Ranked among companies with meaningful EV-to-EBITDA only.
PDEX' s EV-to-EBITDA Range Over the Past 10 Years
Min: -27.4  Med: 2.00 Max: 271.6
Current: 10.96
-27.4
271.6
Current Ratio 4.47
PDEX's Current Ratio is ranked higher than
78% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. PDEX: 4.47 )
Ranked among companies with meaningful Current Ratio only.
PDEX' s Current Ratio Range Over the Past 10 Years
Min: 0.7  Med: 2.95 Max: 7.5
Current: 4.47
0.7
7.5
Quick Ratio 2.57
PDEX's Quick Ratio is ranked higher than
68% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. PDEX: 2.57 )
Ranked among companies with meaningful Quick Ratio only.
PDEX' s Quick Ratio Range Over the Past 10 Years
Min: 0.33  Med: 1.70 Max: 5
Current: 2.57
0.33
5
Days Inventory 108.57
PDEX's Days Inventory is ranked higher than
61% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 126.38 vs. PDEX: 108.57 )
Ranked among companies with meaningful Days Inventory only.
PDEX' s Days Inventory Range Over the Past 10 Years
Min: 76.32  Med: 109.04 Max: 149.66
Current: 108.57
76.32
149.66
Days Sales Outstanding 41.79
PDEX's Days Sales Outstanding is ranked higher than
81% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.03 vs. PDEX: 41.79 )
Ranked among companies with meaningful Days Sales Outstanding only.
PDEX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.44  Med: 42.82 Max: 82.17
Current: 41.79
33.44
82.17
Days Payable 29.82
PDEX's Days Payable is ranked lower than
78% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 55.30 vs. PDEX: 29.82 )
Ranked among companies with meaningful Days Payable only.
PDEX' s Days Payable Range Over the Past 10 Years
Min: 19.51  Med: 32.29 Max: 70.41
Current: 29.82
19.51
70.41

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 2.32
PDEX's Price/Net Current Asset Value is ranked higher than
89% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.84 vs. PDEX: 2.32 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
PDEX' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 0.9  Med: 2.21 Max: 72.3
Current: 2.32
0.9
72.3
Price/Tangible Book 1.97
PDEX's Price/Tangible Book is ranked higher than
72% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.86 vs. PDEX: 1.97 )
Ranked among companies with meaningful Price/Tangible Book only.
PDEX' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.46  Med: 1.59 Max: 16.38
Current: 1.97
0.46
16.38
Price/Projected FCF 3.14
PDEX's Price/Projected FCF is ranked lower than
73% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.89 vs. PDEX: 3.14 )
Ranked among companies with meaningful Price/Projected FCF only.
PDEX' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.01  Med: 1.16 Max: 12.9
Current: 3.14
0.01
12.9
Price/Median PS Value 1.57
PDEX's Price/Median PS Value is ranked lower than
78% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.06 vs. PDEX: 1.57 )
Ranked among companies with meaningful Price/Median PS Value only.
PDEX' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.31  Med: 1.18 Max: 4.11
Current: 1.57
0.31
4.11
Price/Graham Number 1.45
PDEX's Price/Graham Number is ranked higher than
69% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.42 vs. PDEX: 1.45 )
Ranked among companies with meaningful Price/Graham Number only.
PDEX' s Price/Graham Number Range Over the Past 10 Years
Min: 0.26  Med: 1.53 Max: 10.04
Current: 1.45
0.26
10.04
Earnings Yield (Greenblatt) (%) 4.90
PDEX's Earnings Yield (Greenblatt) (%) is ranked higher than
70% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. PDEX: 4.90 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
PDEX' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.7  Med: 7.80 Max: 183.6
Current: 4.9
2.7
183.6
Forward Rate of Return (Yacktman) (%) -27.45
PDEX's Forward Rate of Return (Yacktman) (%) is ranked lower than
97% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.41 vs. PDEX: -27.45 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
PDEX' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -26.6  Med: 5.30 Max: 25
Current: -27.45
-26.6
25

More Statistics

Revenue (TTM) (Mil) $18.95
EPS (TTM) $ 0.17
Beta-0.68
Short Percentage of Float0.42%
52-Week Range $2.22 - 4.40
Shares Outstanding (Mil)4.15
» More Articles for PDEX

Headlines

Articles On GuruFocus.com
Bsquare and Pro-Dex Improved Financial Performance; Avon Products Fakes Bid May 15 2015 
Incentives matter: Pro-Dex (PDEX) Oct 10 2013 
BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector May 14 2013 
Pro-Dex Inc: Are Stories Of Its Death Greatly Exaggerated? Dec 12 2011 
ProDex Inc. Reports Operating Results (10-Q) Feb 10 2011 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 23,946 Shares Nov 06 2009 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 15,000 Shares Nov 04 2009 
ProDex Inc. Reports Operating Results (10-K) Sep 17 2009 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 28,000 Shares Jun 11 2009 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 19,504 Shares Jun 04 2009 

More From Other Websites
PRO DEX INC Files SEC form 8-K, Other Events May 27 2016
Pro-Dex, Inc. :PDEX-US: Earnings Analysis: Q3, 2016 By the Numbers May 19 2016
PRO DEX INC Financials May 19 2016
Pro-Dex, Inc.: Strong price momentum but will it sustain? May 16 2016
Pro-Dex, Inc. Announces Fiscal 2016 Third Quarter and Nine-Month Results May 12 2016
PRO DEX INC Files SEC form 8-K, Results of Operations and Financial Condition May 12 2016
PRO DEX INC Files SEC form 10-Q, Quarterly Report May 12 2016
Pro-Dex, Inc. Announces Fiscal 2016 Third Quarter and Nine-Month Results May 12 2016
PRO DEX INC Files SEC form 8-K, Other Events Apr 19 2016
PRO DEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of... Feb 25 2016
Pro-Dex, Inc.: Strong price momentum but will it sustain? Feb 16 2016
4 Stocks That are Trading With Heavy Volume Today Feb 12 2016
PRO DEX INC Files SEC form 8-K, Results of Operations and Financial Condition Feb 11 2016
PRO DEX INC Files SEC form 10-Q, Quarterly Report Feb 11 2016
Pro-Dex, Inc. Announces Fiscal 2016 Second Quarter And Six-Month Results Feb 11 2016
PRO DEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Jan 08 2016
PRO DEX INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Dec 07 2015
Pro-Dex, Inc. Earnings Q1, 2016 Dec 01 2015
Pro-Dex, Inc. Announces Fiscal 2016 First Quarter Results Nov 10 2015
PRO DEX INC Files SEC form 8-K, Results of Operations and Financial Condition Nov 10 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)